Outcomes of fundoplication: Causes for concern, newer options

Archives of Disease in Childhood

Volumn 90, Issue 10, 2005, Pages 1047-1052

  Hassall, E ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ANTIREFLUX OPERATION; GASTROESOPHAGEAL REFLUX; HUMAN; INTERMETHOD COMPARISON; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; STOMACH FUNDOPLICATION; SYMPTOM; TREATMENT FAILURE;

ANTI-ULCER AGENTS; FOLLOW-UP STUDIES; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HISTAMINE H2 ANTAGONISTS; HUMANS; INFANT; INFANT, NEWBORN; PROTON PUMPS; QUALITY OF LIFE; TREATMENT FAILURE;

EID: 26044436924     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2004.069674     Document Type: Review

References (76)

1. Nelson SP, Chen EH, Syniar GM, et al. Prevalence of symptoms of gastroesophageal reflux during infancy. A pediatric practice-based survey. Pediatric Practice Research Group. Arch Pediatr Adolesc Med 1997;151:569-72.
2. Gupta S, Hassall E, Chiu Y-L, et al. Presenting symptoms of non-erosive and erosive esophagitis in children and adolescents. Gastroenterology 2001;120:A422.
3. El-Serag HB, Gilger MA, Carter J, et al. Childhood GERD is a risk factor for GERD in adolescents and young adults. Am J Gastroenterol 2004;100:806-12.
4. Rudolph CD, Mazur LJ, Liptak SG, et al. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 2001;32:S1-31.
5. Hassall E. Barrett's esophagus: new definitions and approaches in children. J Pediatr Gastroenterol Nutr 1993;16:345-64.
6. Hassall E. Co-morbidities in childhood Barrett's esophagus. J Pediatr Gastroenterol Nutr 1997;25:255-60.
7. Hassall E. Decisions in diagnosing and managing chronic gastroesophageal reflux. J Pediatr 2005;146(suppl 1):S3-12.
8. Di Lorenzo C, Flores A, Hyman PE. Intestinal motility in symptomatic children with fundoplication. J Pediatr Gastroenterol Nutr 1991;12:169-73.
9. Di Lorenzo C, Orenstein S. Fundoplication: friend or foe? J Pediatr Gastroenterol Nutr 2002;34:117-24.
10. Vandenplas Y, Hassall E. Mechanisms of gastroesophageal reflux and gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2002;35:119-36.
11. Hassall E. Wrap session: is the Nissen slipping? Can medical treatment replace surgery for severe gastroesophageal reflux disease in children? Am J Gastroenterol 1995;90:1212-20.
12. Carre I, Johnston BT, Thomas PS, et al. Familial hiatal hernia in a large five generation family confirming true autosomal dominant inheritance. Gut 1999;45:649-52.
13. Murray JA, Camilleri M. The fall and rise of the hiatal hernia. Gastroenterology 2000;119:1779-81.
14. Hassall E. Esophageal biopsy in children-essential, valuable, or a waste of time? It all depends. J Pediatr Gastroenterol Nutr. In press.
15. Nissen R. Gastropexy and fundoplication in surgical treatment of hiatal hernia. Am J Dig Dis 1901;6:954-61.
16. Filler RM, Gross RE. Esophageal hiatus hernia in infants and children. J Thorac Cardiovasc Surg 1964;47:551-65.
17. Cahill JL, Aberdeen E, Waterston DJ. Results of surgical treatment of esophageal hiatal hernia in infancy. Surgery 1969;66:597-602.
18. Curci MR, Dibbins AW. Problems associated with Nissen fundoplication following tracheoesophageal fistula and esophageal atresia repair. Arch Surg 1988;123:618-20.
19. Lindahl H, Rintala R, Louhimo I. Failure of the Nissen fundoplication to control gastroesophageal reflux in esophageal atresia patients. J Pediatr Surg 1989;24:985-7.
20. Pearl RH, Robie DK, Ein SH, et al. Complications of gastroesophageal antireflux surgery in neurologically impaired versus neurologically normal children. J Pediatr Surg 1990;25:1169-73.
21. Caniano DA, Ginn-Pease ME, King DR. The failed antireflux procedure: analysis of risk factors and morbidity. J Pediatr Surg 1990;25:1022-6.
22. Martinez DA, Ginn-Pease ME, Caniano DA. Sequelae of antireflux surgery in profoundly disabled children. J Pediatr Surg 1992;27:267-73.
23. Martinez DA, Ginn-Pease ME, Caniano DA. Recognition of recurrent gastroesophageal reflux following antireflux surgery in the neurologically disabled child: high index of suspicion and definitive evaluation. J Pediatr Surg 1992;27:983-90.
24. Smith CD, Biemann Othersen H, Gogan NJ, et al. Nissen fundoplication in children with profound neurologic disability. High risks and unmet goals. Ann Surg 1992;215:654-9.
25. Ashcraft KW. Gastroesophageal reflux. In: Ashcraft KW, Holder TM, eds. Pediatric surgery. Philadelphia: WB Sounders Company, 1993:270-88.
26. Spitz L, Roth K, Kiely EM, et al. Operation for gastro-oesophageal reflux associated with severe mental retardation. Arch Dis Child 1993;68:347-51.
27. Wheatley MJ, Coran AG, Wesley JR. Efficacy of the Nissen fundoplication in the management of gastroesophageal reflux following esophageal atresia repair. J Pediatr Surg 1993;28:53-5.
28. Taylor LA, Weiner T, Lacey SR, et al. Chronic lung disease is the leading risk factor correlating with the failure (wrap disruption) of antireflux procedures in children. J Pediatr Surg 1994;29:161-6.
29. Dalla Vecchia LK, Grosfeld JL, West KW, et al. Reoperation after Nissen fundoplication in children with gastroesophageal reflux. Ann Surg 1997;226:315-23.
30. Fonkalsrud EW, Ashcraft KW, Coran AG, et al. The surgical management of gastroesophageal reflux in children: a combined hospital study of 7467 patients. Pediatrics 1998;101:419-22.
31. Kimber C, Kiely EM, Spitz L. The failure rate of surgery for gastroesophageal reflux. J Pediatr Surg 1998;33:64-6.
32. Rubiak R, Spitz L, Kiely EM, et al. Effectiveness of fundoplication in early infancy. J Pediatr Surg 1999;34:295-9.
33. Van der Zee DC, Arends NJ, Bax NM. The value of 24-hr pH study in evaluating the results of laparoscopic antireflux surgery in children. Surg Endosc 1999;13:918-21.
34. Esposito C, Montupet P, Amici G, et al. Complications of laparoscopic antireflux surgery in childhood. Surg Endosc 2000;14:622-4.
35. Allal H, Capfier G, Lopez M, et al. Evaluation of 142 consecutive laparoscopic fundoplications in children: effects of the learning curve and technical choice. J Pediatr Surg 2001;36:921-6.
36. Kawahara H, Nakajima K, Yagi M, et al. Mechanisms responsible for recurrent gastroesophageal reflux in neurologically impaired children who underwent laparoscopic Nissen fundoplication. Surg Endosc 2002;16:767-71.
37. Kawahara H, Okuyama H, Kubota A, et al. Can laparoscopic antireflux surgery improve the quality of life in children with neurologic and neuromuscular handicaps? J Pediatr Surg 2004;39:1761-4.
38. Gilger MA, Yeh C, Chiang J, et al. Outcomes of surgical fundoplication in children. Clin Castroenterol Hepatol 2004;2:978-84.
39. Gibbons TE, Stockwell JA, Kreh RP, et al. Population-based epidemiological survey of gastroesophageal reflux disease in hospitalized US children. Gastroenterology 2001;120:A419.
40. Gold BD. Outcomes of pediatric gastroesophageal reflux disease: in the first year of life, in childhood, and in adults. J Pediatr Gastroenterol Nutr 2003;37:S33-9.
41. Diaz DM, Gibbons TE, Heiss K, et al. Antireflux surgery outcomes in pediatric gastroesophageal reflux disease. Am J Gastroenterol. In press.
42. Carlson MA, Frantzides CT. Complications and results of primary minimally invasive antireflux procedures: a review of 10,735 reported cases. Am Coll Surg 2001;193:428-39.
43. Lundell L. Complications after anti-reflux surgery. Best Pract Res Clin Gastroenterol 2004;18:935-45.
44. Harnsberger JK, Corey JJ, Johnson DG, et al. Long-term follow-up of surgery for gastroesophageal reflux in infants and children. J Pediatr 1983;102:505-8.
45. Bais JE, Bartelsman FJ, Bonjer HJ, et al. Laparoscopic or conventional Nissen fundoplication for gastroesophageal reflux disease: randomised clinical trial. Lancet 2000;355:170-4.
46. Deurloo JA, Ekkelkamp S, Bartelsman JFWM, et al. Gastroesophageal reflux: prevalence in adults older than 28 yrs after correction of esophageal atresia. Ann Surg 2003;238:686-9.
47. Rothenberg SS. Experience with 220 consecutive laparoscopic Nissen fundoplications in infants and children. J Pediatr Surg 1998;33:274-8.
48. Vakil N, Shaw M, Kirby R. Clinical effectiveness of laparoscopic fundoplication in a U.S. community. Am J Med 2003;114:1-5.
49. Jackson PG, Gleiber MA, Askari R, et al. Predictors of outcome in 100 consecutive laparoscopic antireflux procedures. Am J Surg 2001;181:231-5.
50. Spechler SJ, Lee E, Ahnen D, et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease. Follow-up of a randomized controlled trial. JAMA 2001;285:2331-8.
51. Sullivan EM, Pelletier EM, Richter JE. Use of acid reduction therapy and medical costs among medically vs. surgically managed GERD patients. Am J Gastroenterol 2002;97:S239.
52. Perdikis G, Hinder RA, Lund RJ, et al. Laparoscopic Nissen fundoplication: where do we stand? Surg Laparosc Endosc 1997;7:17-21.
53. Rantanen TK, Salo JA, Sipponen JT. Fatal and life-threatening complications in antireflux surgery: analysis of 5,502 operations. Br J Surg 1999;86:1573-7.
54. Watson DI, Baigrie RJ, Jaimeson GG. A learning curve for laparoscopic fundoplication. Definable, avoidable, or a waste of time? Ann Surg 1996;224:198-203.
55. Luostarinen MES, Isolauri JO. Surgical experience improves the long-term results of Nissen fundoplication. Scand J Gastroenterol 1999;34:117-20.
56. Marks RD, Richter JE, Rizzo J, et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis. Gastroenterology 1994;106:907-15.
57. Huang J-Q, Hunt RH. Meta-analysis of comparative trials for healing erosive esophagitis with proton pump inhibitors and H2-receptor antagonists. Gastroenterology 1998;114:A154.
58. Huang JQ, Hunt RH. pH, healing rate, and symptom relief in patients with GERD. Yale J Biol Med 1999;72:181-94.
59. Champion GL, Richter JE, Vaezi MF, et al. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology 1994;107:747-54.
60. Nwokolo CU, Smith JT, Gavey C, et al. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine. Aliment Pharmacol Ther 1990;4(suppl 1):29-45.
61. Wilder-Smith CH, Ernst T, Gennoni M, et al. Tolerance to H2-receptor antagonists. Dig Dis Sci 1990;35:976-83.
62. Gunasekaran TS, Hassall E. Efficacy and safety of omeprazole for severe gastroesophageal reflux in children. J Pediatr 1993;123:148-54.
63. Hassall E, Israel DM, Shepherd R, and the International Pediatric Omeprazole Study Group, et al. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. J Pediatr 2000;137:800-7.
64. Israel DM, Hassall E. Omeprazole and other proton pump inhibitors: pharmacology, efficacy and safety, with special reference to use in children. J Pediatr Gastroenterol Nutr 1998;27:568-79.
65. Tolia V, Ferry G, Gunasekaran T, et al. Efficacy of lansoprazole in the treatment of gastroesophageal reflux disease in children. J Pediatr Gastroenterol Nutr 2002;35:S308-18.
66. Gunasekaran T, Gupta S, Gremse D, et al. Lansoprazole in adolescents with gastroesophageal reflux disease. Pharmacokinetics, pharmacodynamics, symptom relief efficacy and tolerability. J Pediatr Gastroenterol Nutr 2002;35(suppl 4):S327-35.
67. Fiedorek S, Tolia V, Huang B, et al. Efficacy and safety of lansoprazole in adolescents with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2005;40:319-27.
68. Klinkenberg-Knol EC, Nelis F, Dent J, et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology 2000;118:661-9.
69. Hassall E, for the International Pediatric Omeprazole Study Group. Omeprazole for maintenance therapy of erosive esophagitis in children. Gastroenterology 2000;118:A658.
70. Hassall E, El-Serag H, Kerr W. Continuous use of proton pump inhibitors (PPI) in children up to 11 yrs duration. Gastroenterology 2005;128:A526.
71. Andersson T, Hassall E, Lundborg P, et al. Pharmacokinetics of orally administered omeprazole in children. International Pediatric Omeprazole Pharmacokinetic Group. Am J Gastroenterol 2000;95:3101-6.
72. Ramakrishnan A, Katz PO. Pharmacologic management of gastroesophageal reflux disease. Curr Treat Options Gastroenterol 2002;5:301-10.
73. Wong RK, Hanson DG, Waring PJ, et al. ENT manifestations of gastroesophageal reflux. Am J Gastroenterol 2000;95(suppl 8):S15-22.
74. Harding SM, Sontag SJ. Asthma and gastroesophageal reflux. Am J Gastroenterol 2000;95(suppl 8):S23-32.
75. Hogan WJ, Shaker R. Life after antireflux surgery. Am J Med 2000;108(4A):181S-191S.
76. Johnson DG. Current thinking on the role of surgery in gastroesophageal reflux. Pediatr Clin N Am 1985;32:1165-79.